Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Other fact-checking organizations have debunked the claim; Reuters and AFP have also fact-checked similar claims that circulated in 2022 and 2023 ...

Calling all Office fans, we are blessed with a Pam skit. And it's all for a good cause, too. Get checked, ladies & gents!

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

La Fondation Publicis has launched the latest initiative from the Working with Cancer Pledge: Screening Time Off, an awareness campaign rallying companies to encourage their employees to take the time ...

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Pharma giant Pfizer has agreed to pay $59 million to settle a federal lawsuit accusing a local biopharmaceutical company of paying "kickbacks" ...

Bourla outlined 2025 priorities, which include improving R&D productivity, achieving margin expansion, and maintaining commercial excellence. He highlighted expectations for nine Phase 3 readouts, 13 ...

Pfizer’s PFE 2024 revenue reached $63.6 billion, near the high end of its $61 billion-$64 billion guidance range. Management ...

Northfield Mount Hermon in Gill is where the late John Mitchell, once a Harwich resident, attended school from 1952-56. He ...